Inventor · disambiguated record
Michael T. Lotze
Also filed as: LOTZE MICHAEL T
74 granted patents·15 pending applications·1,285 citations·filing 1995–2024
99Inventor score
Files withIOVANCE BIOTHERAPEUTICS INC80UNIV PITTSBURGH5UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION2UNIV PITTSBURGH OF COMMONWEALT1
Top patents by PatentIndex Score
89 records- 0199US11998568B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Jun 4, 2024·4 cites·23 claims
- 0299US11541077B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Jan 3, 2023·21 cites·24 claims
- 0399US11529372B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Dec 20, 2022·20 cites·23 claims
- 0499US11517592B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Dec 6, 2022·20 cites·27 claims
- 0599US11344579B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted May 31, 2022·11 cites·20 claims
- 0699US11337998B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted May 24, 2022·6 cites·19 claims
- 0799US11304979B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Apr 19, 2022·6 cites·19 claims
- 0899US11291687B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Apr 5, 2022·6 cites·16 claims
- 0999US11273180B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Mar 15, 2022·6 cites·19 claims
- 1099US11273181B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Mar 15, 2022·7 cites·19 claims
- 1199US11241456B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Feb 8, 2022·7 cites·20 claims
- 1299US11202803B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Dec 21, 2021·6 cites·20 claims
- 1399US11202804B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Dec 21, 2021·7 cites·20 claims
- 1499US11083752B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·22 cites·20 claims
- 1599US11052115B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Jul 6, 2021·12 cites·22 claims
- 1699US11052116B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Jul 6, 2021·13 cites·24 claims
- 1799US11040070B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 22, 2021·13 cites·14 claims
- 1899US11013770B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted May 25, 2021·28 cites·24 claims
- 1999US11007225B1Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted May 18, 2021·7 cites·29 claims
- 2099US11007226B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted May 18, 2021·13 cites·20 claims
- 2199US10953046B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 23, 2021·28 cites·25 claims
- 2299US10953047B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 23, 2021·28 cites·26 claims
- 2399US10946044B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 16, 2021·28 cites·15 claims
- 2499US10946045B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 16, 2021·28 cites·15 claims
- 2599US10933094B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·28 cites·26 claims
- 2699US10925900B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Feb 23, 2021·19 cites·15 claims
- 2799US10905718B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted Feb 2, 2021·25 cites·24 claims
- 2899US10894063B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Jan 19, 2021·26 cites·46 claims
- 2999US10695372B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·17 cites·15 claims
- 3099US10653723B1Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2020·Granted May 19, 2020·32 cites·30 claims
- 3199US10646517B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2019·Granted May 12, 2020·17 cites·23 claims
- 3299US10639330B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2019·Granted May 5, 2020·17 cites·11 claims
- 3399US10537595B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·35 cites·22 claims
- 3499US10463697B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·22 cites·21 claims
- 3599US10420799B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·26 cites·11 claims
- 3699US10398734B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·25 cites·15 claims
- 3799US10363273B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Jul 30, 2019·50 cites·29 claims
- 3899US10272113B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Apr 30, 2019·37 cites·23 claims
- 3999US10166257B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Jan 1, 2019·48 cites·20 claims
- 4099US10130659B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2018·Granted Nov 20, 2018·55 cites·29 claims
- 4198US12485145B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2024·Granted Dec 2, 2025·1 cites·21 claims
- 4298US12194061B2Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapyIOVANCE BIOTHERAPEUTICS INC·Filed 2022·Granted Jan 14, 2025·2 cites·22 claims
- 4398US11369637B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 28, 2022·6 cites·25 claims
- 4498US11364266B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 21, 2022·6 cites·25 claims
- 4598US11351199B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 7, 2022·6 cites·25 claims
- 4698US11351197B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 7, 2022·5 cites·20 claims
- 4798US11351198B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 7, 2022·19 cites·20 claims
- 4898US11344580B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted May 31, 2022·5 cites·20 claims
- 4998US11344581B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted May 31, 2022·6 cites·24 claims
- 5098US11311578B2Restimulation of cryopreserved tumor infiltrating lymphocytesIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Apr 26, 2022·6 cites·20 claims
Showing the top 50 of 89 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael T. Lotze files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →